Lower epicardial adipose tissue adiponectin in patients with metabolic syndrome

Cytokine

Volumn 54, Issue 2, 2011, Pages 185-190

  Teijeira Fernandez, E ^a   Eiras, S ^a   Grigorian Shamagian, L ^a   Salgado Somoza, A ^a   Delgado, C ^a   Gonzalez Juanatey, J R ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

Adiponectin; Epicardial adipose tissue; Metabolic syndrome; Obesity

Indexed keywords

ADIPONECTIN; MESSENGER RNA;

AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPICARDIUM; FEMALE; GENE EXPRESSION REGULATION; HEART FAILURE; HUMAN; HUMAN TISSUE; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SUBCUTANEOUS FAT;

ADIPONECTIN; ADIPOSE TISSUE; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; PERICARDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79953055213     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.01.016     Document Type: Article

References (32)

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-2497.
2. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288(21):2709-2716.
3. Iacobellis G., Ribaudo M.C., Assael F., Vecci E., Tiberti C., Zappaterreno A. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003 Nov, 88(11):5163-5168.
4. Rosito G.A., Massaro J.M., Hoffmann U., Ruberg F.L., Mahabadi A.A., Vasan R.S., et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham heart study. Circulation 2008, 117(5):605-613.
5. Mazurek T., Zhang L., Zalewski A., Mannion J.D., Diehl J.T., Arafat H., et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003, 108(20):2460-2466.
6. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257(1):79-83.
7. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7(8):941-946.
8. Tschritter O., Fritsche A., Thamer C., Haap M., Shirkavand F., Rahe S., et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003, 52(2):239-243.
9. Yokota T., Oritani K., Takahashi I., Ishikawa J., Matsuyama A., Ouchi N., et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000, 96(5):1723-1732.
10. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamoto Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001, 103(8):1057-1063.
11. Tian L., Luo N., Klein R.L., Chung B.H., Garvey W.T., Fu Y. Adiponectin reduces lipid accumulation in macrophage foam cells. Atherosclerosis 2009, 202(1):152-161.
12. Chen H., Montagnani M., Funahashi T., Shimomura I., Quon M.J. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003, 278(45):45021-45026.
13. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86(5):1930-1935.
14. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000, 20(6):1595-1599.
15. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23(1):85-89.
16. Iwashima Y., Katsuya T., Ishikawa K., Ouchi N., Ohishi M., Sugimoto K., et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004, 43(6):1318-1323.
17. Kistorp C., Faber J., Galatius S., Gustafsson F., Frystyk J., Flyvbjerg A., et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005, 112(12):1756-1762.
18. Sattar N., Wannamethee G., Sarwar N., Tchernova J., Cherry L., Wallace A.M., et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 2006, 114(7):623-629.
19. Dekker J.M., Funahashi T., Nijpels G., Pilz S., Stehouwer C.D., Snijder M.B., et al. Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab 2008, 93(4):1489-1496.
20. Santaniemi M., Kesaniemi Y.A., Ukkola O. Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur J Endocrinol 2006, 155(5):745-750.
21. Whitehead J.P., Richards A.A., Hickman I.J., Macdonald G.A., Prins J.B. Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006, 8(3):264-280.
22. Matsushita K., Yatsuya H., Tamakoshi K., Wada K., Otsuka R., Takefuji S., et al. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol 2006, 26(4):871-876.
23. Choi K.M., Lee J., Lee K.W., Seo J.A., Oh J.H., Kim S.G., et al. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol (Oxf) 2004, 61(1):75-80.
24. Teijeira-Fernandez E., Eiras S., Grigorian Shamagian L., Salgado Somoza A., Martinez Comendador J.M., Gonzalez-Juanatey J.R. Diabetic and nondiabetic patients express similar adipose tissue adiponectin and leptin levels. Int J Obes (Lond) 2010, 34(7):1200-1208.
25. Iglesias M.J., Eiras S., Pineiro R., Lopez-Otero D., Gallego R., Fernandez A.L., et al. [Gender differences in adiponectin and leptin expression in epicardial and subcutaneous adipose tissue. Findings in patients undergoing cardiac surgery]. Rev Esp Cardiol 2006, 59(12):1252-1260.
26. Teijeira-Fernandez E., Eiras S., Grigorian-Shamagian L., Fernandez A., Adrio B., Gonzalez-Juanatey J.R. Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension. J Hum Hypertens 2008, 22(12):856-863.
27. Eiras S., Teijeira-Fernandez E., Shamagian L.G., Fernandez A.L., Vazquez-Boquete A., Gonzalez-Juanatey J.R. Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue. Cytokine 2008, 43(2):174-180.
28. Iacobellis G., Pistilli D., Gucciardo M., Leonetti F., Miraldi F., Brancaccio G., et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005, 29(6):251-255.
29. Arita Y., Kihara S., Ouchi N., Maeda K., Kuriyama H., Okamoto Y., et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002, 105(24):2893-2898.
30. Rasouli N., Yao-Borengasser A., Miles L.M., Elbein S.C., Kern P.A. Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression. Am J Physiol Endocrinol Metab 2006, 290(1):E42-E46.
31. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001, 50(9):2094-2099.
32. Coats A.J. Ethical authorship and publishing. Int J Cardiol 2009, 131(2):149-150.